Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 15,211 |
| Marketable Securities | 1,498 |
| Receivables | 3,245 |
| Inventories | 3,702 |
| Other current assets | 796 |
| TOTAL | $24,452 |
| Non-Current Assets | |
| PPE Net | 5,478 |
| TOTAL | $5,478 |
| Total Assets | $29,985 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 2,089 |
| Accrued Expenses | 3,552 |
| Other current liabilities | 3,193 |
| TOTAL | $9,343 |
| Non-Current Liabilities | |
| Long Term Debt | 4,895 |
| Other Non-Current Liabilities | 338 |
| TOTAL | $5,233 |
| Total Liabilities | $16,384 |
| Shareholders' Equity | |
| Common Shares | 574 |
| Retained earnings | -83,406 |
| TOTAL | $13,602 |
| Total Liabilities And Equity | $29,986 |